{"id":59954,"date":"2024-09-27T12:06:11","date_gmt":"2024-09-27T12:06:11","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/09\/27\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/"},"modified":"2024-09-27T12:06:11","modified_gmt":"2024-09-27T12:06:11","slug":"aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/","title":{"rendered":"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment"},"content":{"rendered":"<div>\n<p><em>Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET<\/em><\/p>\n<p align=\"justify\">OCALA, Fla., Sept.  27, 2024  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=96F6EB_wi5c3Qk1Ih16V6l8CNgjqr6trpvYTeH5S6tLPaa2rMmKNtZWWk4M0ivN3u-r-0EhSWivt5vLlmvGbY-HHuazPZCuOAmA8DYl_5uM=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>AIM ImmunoTech Inc.<\/strong><\/a><strong> (NYSE American: AIM)\u00a0<\/strong>(\u201cAIM\u201d or the \u201cCompany\u201d) today announced that <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZmIKFc_nTC8nNjVH5-KFHYulXN58hv4wG05yYtaQa-GH1uTNPJDFNMJI56KJoDVT287dVgIlAvlyyZ0CMB2aJnZRiuoLqKsOqwjOj656bTWv_KH6hKbZsW8196nQGudT3wEevFAKDD5p9fzMC9Xy0Q==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Thomas K. Equels, Chief Executive Officer\">Thomas K. Equels, Chief Executive Officer<\/a> of AIM will participate in a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j6sI7ixbSTKLs-yzjOIppD-gj0Ew5hUKxPfkWPHqnuTedal8PqWmURVBj54nh7uPSW6OPF2yPNktQYkuSnAbHFbj8wdm_14i36mT2aAGgYCAOrTnCSnx1rQMsUpQzVVrQ0-2aBlldJNYy59F5ewmMso99F_rpZCWRXRbsxWIB1GvSylfHmY8kBwe7mCJWRqa\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Virtual Investor CEO Connect\">Virtual Investor CEO Connect<\/a> segment on Wednesday, October 2, 2024 at 4:00 PM ET.<\/p>\n<p align=\"justify\">As part of the event, Mr. Equels will provide a brief presentation, followed by an interactive Q&amp;A session. Investors and interested parties will have the opportunity to submit questions live during the event. Questions can also be pre-submitted leading up to the event by emailing <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ioKVOeqAcJLK5_987Oc2Kc2gQOF2w8ls3jpqjUE9b0foAd18SVmgbuRD_dywlUMoIQXvwBSlIyn8V74zxYZhZA==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"AIM@jtcir.com\">AIM@jtcir.com<\/a>. Mr. Equels will answer as many questions as possible in the time allowed.<\/p>\n<p>A <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bV4ZNlvwSp7-zUf1n3YTfbWNEqMRG23NgmTBdXxZoF2qukUTM5i4ZSDO6lzupTS_Qm_cCxXFV14b0Mw7FNCaKHHW5aoVB7AmBDtfLhVNhTA9y752Dao_E2aoj6rY2vzzh-HOiiWsB5bOkEYeTm5fHMSRDmesXEFJt86H5tAUTWM=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"live video webcast\">live video webcast<\/a> of the presentation will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pScUNFS0ax_-RrkOhbypmQfR3Art5Ott6NAh8zRtmiL7ClTh6xcSd837dJkf2MB0Rd6sMVNpSmtUOYVS_QUlRQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Events\">Events<\/a> page of the Company\u2019s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8N5EP-g-7kDiMdsjDJ8O2p9UwDZ81qz7hnfGPHLVQ_cSeVU8fYg_bSWTGrD11X18p4BxAm7_BWIqDL6-TIGmJg==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"aimimmuno.com\">aimimmuno.com<\/a>). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.<\/p>\n<p><strong>About AIM ImmunoTech Inc.<\/strong><\/p>\n<p align=\"justify\">AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company\u2019s lead product is a first-in-class investigational drug called Ampligen<sup>\u00ae<\/sup>\u00a0(rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.<\/p>\n<p align=\"justify\">For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8N5EP-g-7kDiMdsjDJ8O2gieB-G6wgxZANH15iFWjgq72z9U3iQcCN1__wSftptXRy-3aIDxqpQzxcwcsX328w==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"aimimmuno.com\">aimimmuno.com<\/a>\u00a0and connect with the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M2sxOs4Lb11VgL06D5pMLTfvspfBicz9Z9OSjAOjDHiZX6sQ186rKmR4zspTl34ZRpIO5cqTEDXc-XHRdtbaow==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"X\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=leG1gEMhjfHCz45KdP8_iP7PDOL4Df5fZgjTtb2fYTkk0AjD58lBN-Iq9sdkQrn4MGR2ugSihqVpzJJYeGz4MIpsEkEkdCRxbX_8d9PzF6FC1S3V8Fr03n71VcMQM4du\" rel=\"nofollow noopener\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L8OXOmUFyn6HUTf91yUG3aCMHymtkdAce1zPorxx15i8sqTwuy0s7mGKJJdnPVq84xmdqWvuYPq1tad5Gb4u2kJV9dyRFKOf7kMkysYxFYA=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Facebook\">Facebook<\/a>.<\/p>\n<pre>CONTACT: Investor Contact:\r\n\r\nJTC Team, LLC\r\nJenene Thomas\r\n908.824.0775\r\nAIM@jtcir.com<\/pre>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MzEwNmJiZDQtNTA3Yi00Mzg2LTkxZjEtYWJmMGMzNzk4OGQxLTEwMzQ3MzU=\/tiny\/AIM-ImmunoTech-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET OCALA, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) &#8212; AIM ImmunoTech Inc. (NYSE American: AIM)\u00a0(\u201cAIM\u201d or the \u201cCompany\u201d) today announced that Thomas K. Equels, Chief Executive Officer of AIM will participate in a Virtual Investor CEO [&#8230;]\n","protected":false},"author":1,"featured_media":59955,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-59954","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment\" \/>\n<meta property=\"og:description\" content=\"Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET OCALA, Fla., Sept. 27, 2024 (GL\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-27T12:06:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/09\/AIM-ImmunoTech-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment\",\"datePublished\":\"2024-09-27T12:06:11+00:00\",\"dateModified\":\"2024-09-27T12:06:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/\"},\"wordCount\":262,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/\",\"name\":\"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-09-27T12:06:11+00:00\",\"dateModified\":\"2024-09-27T12:06:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/","og_locale":"en_US","og_type":"article","og_title":"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment","og_description":"Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, October 2nd at 4:00 PM ET OCALA, Fla., Sept. 27, 2024 (GL","og_url":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-09-27T12:06:11+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/09\/AIM-ImmunoTech-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment","datePublished":"2024-09-27T12:06:11+00:00","dateModified":"2024-09-27T12:06:11+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/"},"wordCount":262,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/","url":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/","name":"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-09-27T12:06:11+00:00","dateModified":"2024-09-27T12:06:11+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/aim-immunotech-to-participate-in-virtual-investor-ceo-connect-segment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/59954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=59954"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/59954\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/59955"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=59954"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=59954"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=59954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}